JILL PORTER: Open Payments
NPI 1053441881 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 22 payments from 12 companies in 2025. Trend: 2023 $605 · 2024 $284 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $204 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| ABBVIE INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Exact Sciences Corporation | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $19 |
Products named: Auvelity, REPATHA, OTEZLA, TRELEGY ELLIPTA, GARDASIL 9, LEQVIO, Cologuard Collection Kit, TRINTELLIX.
Industry payments across MD — which companies pay providers there.
